Kathy Galante
Investor Relations Contact chez IVERIC BIO, INC.
Postes actifs de Kathy Galante
Sociétés | Poste | Début | Fin |
---|---|---|---|
IVERIC BIO, INC. | Investor Relations Contact | 13/11/2013 | - |
Public Communications Contact | 13/11/2013 | 01/05/2021 |
Historique de carrière de Kathy Galante
Anciens postes connus de Kathy Galante
Sociétés | Poste | Début | Fin |
---|---|---|---|
Burns McClellan, Inc.
Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Burns McClellan, Inc. provides public and investor relations services. The private company is based in New York, NY. | Corporate Officer/Principal | 01/04/2011 | 01/11/2013 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Public Communications Contact | - | - |
OSI PHARMACEUTICALS, INC. | Public Communications Contact | - | - |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Public Communications Contact | 3 |
Investor Relations Contact | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Burns McClellan, Inc.
Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Burns McClellan, Inc. provides public and investor relations services. The private company is based in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Kathy Galante
- Expérience